Cadian Capital Management, LP Mirum Pharmaceuticals, Inc. Transaction History
Cadian Capital Management, LP
- $1.95 Billion
- Q3 2024
A detailed history of Cadian Capital Management, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 475,714 shares of MIRM stock, worth $20.8 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
475,714
Previous 1,235,121
61.48%
Holding current value
$20.8 Million
Previous $42.2 Million
56.07%
% of portfolio
0.95%
Previous 2.1%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$287 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$196 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$151 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$141 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$134 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.61B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...